Table 1 |
||
|
Demographic and clinical data of the rheumatoid arthritis patients and arthritis controls |
||
|
Parameter |
RA patients (n = 8) |
AC patients (n = 3) |
|
|
||
|
Age (years) |
58 (34–69) |
56 (49–68) |
|
Sex (no. of males/females) |
4/4 |
3/0 |
|
Disease duration (months) |
60 (4–360) |
2 (1–12) |
|
Rheumatoid factor |
7 positive; 1 negative |
1 positive; 2 negative |
|
Tender joint count |
9 (5–15) |
1 (1–2) |
|
Swollen joint count |
11 (5–19) |
2 (1–23) |
|
ESR (mm/h) |
46 (25–69) |
38 (28–43) |
|
Erosive disease |
6 positive; 2 negative |
None |
|
No. of DMARDs |
4.5 (1–5) |
0 |
|
Leukocytes in SF (109/l) |
6.3 (4.5–7.0) |
4.3 (4.2–4.5) |
|
CRP (mg/l) |
34 (8–97) |
4 (<3–26) |
|
|
||
|
Results are medians, with ranges in parentheses. AC, arthritis control; CRP, C-reactive protein in plasma; DMARDs, disease-modifying antirheumatic drugs; ESR, erythrocyte sedimentation rate; RA, rheumatoid arthritis; SF, synovial fluid. |
||
|
Berckmans et al. Arthritis Research & Therapy 2005 7:R536 doi:10.1186/ar1706 |
||
